Monsalve F, Rucabado L, Ruano M, Cuñat J, Lacueva V, Viñuales A
Intensive Care Med. 1987;13(4):244-8. doi: 10.1007/BF00265112.
We studied the effect of thiopental loading during resuscitation of 53 patients following cardiopulmonary arrest and compared the outcome with that found in 54 patients treated conventionally in the 30 previous months. Thiopental therapy (10 mg/kg i.v.) was begun within 30 min of the arrest once hemodynamic stability had been established. Thiopental infusion (20 mg/kg over 6 h) was followed by phenobarbital sodium (125 mg every 12 h), tolerance to the initial dose having been assessed. The in-hospital mortality rate for both groups was similar. In patients with ischemic heart disease, the mortality rate within the first 6 h was significantly higher in the thiopental group (p less than 0.05), although for the remaining patients there were more survivors among the thiopental treated patients (p less than 0.05). Excluding the patients who died within the first 6 h, 61% of the patients in the thiopental group survived cardiac arrest with normal cerebral performance, whereas only 37% in the standard treatment group showed normal functional outcome (p less than 0.03). These results suggest a favorable neurologic effect of thiopental loading during resuscitation of patients without ischemic heart disease. In patients with ischemic heart disease, an initial hemodynamic deterioration may contribute to minimising the beneficial effect of barbiturate therapy.
我们研究了硫喷妥钠负荷剂量在53例心脏骤停患者复苏过程中的作用,并将结果与前30个月常规治疗的54例患者进行比较。一旦血流动力学稳定,在心脏骤停后30分钟内开始硫喷妥钠治疗(静脉注射10mg/kg)。硫喷妥钠输注(6小时内20mg/kg)后给予苯巴比妥钠(每12小时125mg),已评估对初始剂量的耐受性。两组的院内死亡率相似。在缺血性心脏病患者中,硫喷妥钠组在前6小时内的死亡率显著更高(p<0.05),尽管对于其余患者,硫喷妥钠治疗的患者中幸存者更多(p<0.05)。排除在前6小时内死亡的患者,硫喷妥钠组61%的患者心脏骤停后存活且脑功能正常,而标准治疗组只有37%的患者显示功能结局正常(p<0.03)。这些结果表明,在无缺血性心脏病患者的复苏过程中,硫喷妥钠负荷剂量具有良好的神经学效应。在缺血性心脏病患者中,初始血流动力学恶化可能会降低巴比妥类药物治疗的有益效果。